Ian Nisonson, M.D. Autism Spectrum Conference Series Evaluation

Please select one: *

I am in active clinical practice

I am retired

I am a student

Other

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients	The skills learned in this CME course will be applied in the treatment of my patients - 5	The skills learned in this CME course will be applied in the treatment of my patients - 4	The skills learned in this CME course will be applied in the treatment of my patients - 3	The skills learned in this CME course will be applied in the treatment of my patients - 2	The skills learned in this CME course will be applied in the treatment of my patients - 1	The skills learned in this CME course will be applied in the treatment of my patients - NA

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Recognize the early symptoms of autism and the typical priorities for treatment and intervention.	Recognize the early symptoms of autism and the typical priorities for treatment and intervention. - 5	Recognize the early symptoms of autism and the typical priorities for treatment and intervention. - 4	Recognize the early symptoms of autism and the typical priorities for treatment and intervention. - 3	Recognize the early symptoms of autism and the typical priorities for treatment and intervention. - 2	Recognize the early symptoms of autism and the typical priorities for treatment and intervention. - 1
Evaluate new advances in capitalizing eye-tracking research of early social development to generate cost-effective and community-viable solutions to increase access to early detection and diagnosis for young children with autism and related social-communication and language delays.	Evaluate new advances in capitalizing eye-tracking research of early social development to generate cost-effective and community-viable solutions to increase access to early detection and diagnosis for young children with autism and related social-communication and language delays. - 5	Evaluate new advances in capitalizing eye-tracking research of early social development to generate cost-effective and community-viable solutions to increase access to early detection and diagnosis for young children with autism and related social-communication and language delays. - 4	Evaluate new advances in capitalizing eye-tracking research of early social development to generate cost-effective and community-viable solutions to increase access to early detection and diagnosis for young children with autism and related social-communication and language delays. - 3	Evaluate new advances in capitalizing eye-tracking research of early social development to generate cost-effective and community-viable solutions to increase access to early detection and diagnosis for young children with autism and related social-communication and language delays. - 2	Evaluate new advances in capitalizing eye-tracking research of early social development to generate cost-effective and community-viable solutions to increase access to early detection and diagnosis for young children with autism and related social-communication and language delays. - 1
Identify quantitative and cost-effective tool for the early diagnosis and assessment of autism; the clinical validation data that led to its FDA clearance for broad use in the community; and its potential for making the diagnostics process more efficient and accessible while maintaining high quality.	Identify quantitative and cost-effective tool for the early diagnosis and assessment of autism; the clinical validation data that led to its FDA clearance for broad use in the community; and its potential for making the diagnostics process more efficient and accessible while maintaining high quality. - 5	Identify quantitative and cost-effective tool for the early diagnosis and assessment of autism; the clinical validation data that led to its FDA clearance for broad use in the community; and its potential for making the diagnostics process more efficient and accessible while maintaining high quality. - 4	Identify quantitative and cost-effective tool for the early diagnosis and assessment of autism; the clinical validation data that led to its FDA clearance for broad use in the community; and its potential for making the diagnostics process more efficient and accessible while maintaining high quality. - 3	Identify quantitative and cost-effective tool for the early diagnosis and assessment of autism; the clinical validation data that led to its FDA clearance for broad use in the community; and its potential for making the diagnostics process more efficient and accessible while maintaining high quality. - 2	Identify quantitative and cost-effective tool for the early diagnosis and assessment of autism; the clinical validation data that led to its FDA clearance for broad use in the community; and its potential for making the diagnostics process more efficient and accessible while maintaining high quality. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so? *

Please provide any additional comments or suggestions.

Name

You are here

Ian Nisonson, M.D. Autism Spectrum Conference Series Evaluation